Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Clinical trial NCT03370276 · COMPLETED

Trial details

NCT number: NCT03370276
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Oropharynx Squamous Cell Carcinoma of the Larynx Squamous Cell Carcinoma of the Oral Cavity Squamous Cell Carcinoma of the Hypopharynx Squamous Cell Carcinoma of the Paranasal Sinus Head and Neck Squamous Cell Carcinoma Squamous Cell Cancer Head and Neck Carcinoma

Start date: 2017-12-20
Primary completion: 2021-09-04
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.